Table 2.
Patient Characteristics (n = 56)
| Total Sample | Group A | Group B | CCAS | |||||
|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | |
| Gender | ||||||||
| Male | 31 | 55.4 | 10 | 55.6 | 11 | 61.1 | 10 | 50.0 |
| Female | 25 | 44.6 | 8 | 44.4 | 7 | 38.9 | 10 | 50.0 |
| Histology | ||||||||
| Medulloblastoma | 19 | 33.9 | 0 | 0 | 10 | 55.6 | 9 | 45.0 |
| Pilocytic astrocytoma | 28 | 50.0 | 18 | 100.0 | 1 | 5.6 | 9 | 45.0 |
| Posterior fossa ependymoma | 9 | 16.1 | 0 | 0 | 7 | 38.9 | 2 | 10.0 |
| Treatment | ||||||||
| Resection | 26 | 46.4 | 18 | 100.0 | 0 | 0 | 8 | 40.0 |
| + Chemotherapy | 4 | 7.1 | 0 | 0 | 0 | 0 | 4 | 20.0 |
| + Radiotherapy | 1 | 1.8 | 0 | 0 | 1 | 5.6 | 0 | 0 |
| + Chemo-/radiotherapy | 25 | 44.6 | 0 | 0 | 17 | 94.4 | 8 | 40.0 |
| Hydrocephalus | ||||||||
| Yes | 38 | 67.9 | 9 | 50.0 | 15 | 83.3 | 14 | 70.0 |
| No | 18 | 32.1 | 9 | 50.0 | 3 | 16.7 | 6 | 30.0 |
| CM | ||||||||
| Yes | 6 | 10.7 | 1 | 5.6 | 3 | 16.7 | 2 | 10.0 |
| No | 50 | 89.3 | 17 | 94.4 | 15 | 83.3 | 18 | 90.0 |
| Tumor relapse | ||||||||
| Yes | 10 | 17.9 | 0 | 0 | 5 | 27.8 | 5 | 25.0 |
| No | 46 | 82.1 | 18 | 100.0 | 13 | 72.2 | 15 | 75.0 |
| Total Sample | Group A | Group B | CCAS | |||||
| Mean (SD) | Range | Mean (SD) | Range | Mean (SD) | Range | Mean (SD) | Range | |
| Age ata | ||||||||
| Tumor diagnosis | 7.23 (4.48) | 1-17 | 7.50 (3.90) | 2-15 | 8.06 (5.13) | 1-17 | 6.25 (4.32) | 1-16 |
| Neuropsychological examination 1 | 9.93 (4.40) | 4-21 | 9.72 (4.87) | 4-21 | 10.67 (4.79) | 4-20 | 9.45 (3.68) | 4-17 |
| Neuropsychological examination 2 | 14.71 (4.86) | 5-29 | 14.33 (5.22) | 7-27 | 14.67 (5.65) | 5-29 | 15.10 (3.91) | 7-23 |
| Time betweena | ||||||||
| Tumor diagnosis and neurocognitive test 1 | 2.52 (2.59) | 0-13 | 2.17 (3.29) | 0-13 | 2.33 (2.11) | 0-7 | 3.00 (2.29) | 0-8 |
| Tumor diagnosis and neurocognitive test 2 | 7.20 (4.30) | 1-19 | 6.72 (4.86) | 1-19 | 6.17 (3.45) | 1-13 | 8.55 (4.31) | 1-16 |
Abbreviations: CCAS, patients with cerebellar cognitive affective syndrome (n = 20); CM, cerebellar mutism; group A, patients with tumor resection only (n = 18); group B, patients with tumor resection and subsequent chemo-/radiotherapy (n = 18); SD, standard deviation.
aAge and time data are given in years.